pyridazine has been researched along with Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conway, JG; Demarest, KT; Gaul, MD; Ho, G; Kuo, GH; Lang, W; Lenhard, JM; Li, Y; Liang, Y; Lu, H; Murray, WV; Rano, T; Tang, Y; Yang, SM | 1 |
| Conlon, P; Dyck, B; Goodfellow, VS; Grey, J; Heise, CE; Madan, A; Markison, S; Norton, C; Rowbottom, MW; Saunders, J; Schwarz, D; Sorensen, K; Tamiya, J; Vickers, T; Wen, J; Zhang, M; Zhao, L | 1 |
2 other study(ies) available for pyridazine and Obesity
| Article | Year |
|---|---|
4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: part 2. Pyridazine-based analogs.
Topics: Administration, Oral; Animals; Body Weight; Bridged Bicyclo Compounds; Drug Design; Enzyme Inhibitors; Half-Life; Humans; Mice; Microsomes, Liver; Obesity; Pyridazines; Rats; Rats, Sprague-Dawley; Rats, Zucker; Stearoyl-CoA Desaturase; Structure-Activity Relationship | 2014 |
A thienopyridazinone-based melanin-concentrating hormone receptor 1 antagonist with potent in vivo anorectic properties.
Topics: Animals; Appetite Depressants; Biological Availability; Body Weight; Brain; Eating; Half-Life; Male; Obesity; Permeability; Pyridazines; Rats; Rats, Sprague-Dawley; Receptors, Somatostatin; Stereoisomerism; Structure-Activity Relationship; Thiophenes | 2006 |